73 related articles for article (PubMed ID: 22951322)
1. Effects of endokinin A/B and endokinin C/D on the antinociception properties of hemopressin in mice.
Zhou L; Jin Q; Yang Y; Liu Z; Li X; Dong S; Zhao L
Peptides; 2012 Nov; 38(1):70-80. PubMed ID: 22951322
[TBL] [Abstract][Full Text] [Related]
2. Effects of Endokinin A/B and Endokinin C/D on the modulation of pain in mice.
Yang Y; Dong S
Peptides; 2010 Jan; 31(1):94-100. PubMed ID: 19854230
[TBL] [Abstract][Full Text] [Related]
3. Interaction of endokinin A/B and (Mpa(6))-γ2-MSH-6-12 in pain regulation in mice.
Zhou L; Yang Q; He C; Wei C; Yang Y; Dong S
Neuropeptides; 2015 Oct; 53():79-84. PubMed ID: 26145509
[TBL] [Abstract][Full Text] [Related]
4. Effects of endokinin A/B, endokinin C/D, and endomorphin-1 on the regulation of mean arterial blood pressure in rats.
Jin Q; Lu L; Yang Y; Dong S
Peptides; 2011 Dec; 32(12):2428-35. PubMed ID: 22037058
[TBL] [Abstract][Full Text] [Related]
5. Effects of Endokinin A/B and Endokinin C/D on the antinociception of Endomorphin-1 in mice.
Yang Y; Ni Z; Dong S
Peptides; 2010 Apr; 31(4):689-95. PubMed ID: 20035812
[TBL] [Abstract][Full Text] [Related]
6. Pain regulation of endokinin A/B or endokinin C/D on chimeric peptide MCRT in mice.
He C; Gong J; Yang L; Zhang H; Dong S; Zhou L
Can J Physiol Pharmacol; 2016 Sep; 94(9):955-60. PubMed ID: 27285300
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal administration of the common carboxyl-terminal decapeptide in endokinin A and endokinin B evokes scratching behavior and thermal hyperalgesia in the rat.
Yoshioka D; Takebuchi F; Nishimori T; Naono R; Ikeda T; Nakayama T
Neurosci Lett; 2006 Dec; 410(3):193-7. PubMed ID: 17101218
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice.
Fu CY; Zhao YL; Dong L; Chen Q; Ni JM; Wang R
Brain Behav Immun; 2008 Aug; 22(6):850-60. PubMed ID: 18262387
[TBL] [Abstract][Full Text] [Related]
9. MCRT, a chimeric peptide based on morphiceptin and PFRTic-NH
Zhang J; He C; Pi X; Wang Y; Zhou L; Dong S
Eur J Pharmacol; 2016 Dec; 792():33-37. PubMed ID: 27784644
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous injection of endokinin C/D attenuates carrageenan-induced inflammation.
Naono-Nakayama R; Sunakawa N; Ikeda T; Matsushima O; Nishimori T
Peptides; 2010 Sep; 31(9):1767-71. PubMed ID: 20638946
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characteristics of endokinin C/D-derived peptides in nociceptive and inflammatory processing in rats.
Naono-Nakayama R; Sunakawa N; Ikeda T; Matsushima O; Nishimori T
Peptides; 2011 Dec; 32(12):2407-17. PubMed ID: 22074956
[TBL] [Abstract][Full Text] [Related]
13. Leucine at the carboxyl-terminal of endokinins C and D contributes to elicitation of the antagonistic effect on substance P in rat pain processing.
Naono R; Nakayama T; Ikeda T; Matsushima O; Nishimori T
Brain Res; 2007 Aug; 1165():71-80. PubMed ID: 17655832
[TBL] [Abstract][Full Text] [Related]
14. Anxiogenic-like effects induced by hemopressin in rats.
Fogaça MV; Sonego AB; Rioli V; Gozzo FC; Dale CS; Ferro ES; Guimarães FS
Pharmacol Biochem Behav; 2015 Feb; 129():7-13. PubMed ID: 25462856
[TBL] [Abstract][Full Text] [Related]
15. Endokinin A/B stimulates rat gastric motility through myogenic NK1 receptors located in the fundus.
Zhang J; Ma C; Wang R; He C; Li H; Dong S
Can J Physiol Pharmacol; 2020 Oct; 98(10):691-699. PubMed ID: 32365302
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
Lessard A; Couture R
Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
[TBL] [Abstract][Full Text] [Related]
17. Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.
Pan JX; Wang ZL; Li N; Han ZL; Li XH; Tang HH; Wang P; Zheng T; Fang Q; Wang R
Neurosci Lett; 2014 Aug; 578():187-91. PubMed ID: 25010019
[TBL] [Abstract][Full Text] [Related]
18. Tachykinin NK(3)receptor involvement in anxiety.
Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC
Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice.
Zeng P; Li S; Zheng YH; Liu FY; Wang JL; Zhang DL; Wei J
Peptides; 2014 May; 55():103-9. PubMed ID: 24607724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
